1 in 8 adults has taken Ozempic or other GLP-1 drug: Survey

A new poll from the health policy nonprofit KFF found that one in eight adults say they've taken a GLP-1 agonist, the obesity and diabetes medications that include Ozempic, Mounjaro and Zepbound.

Among those surveyed, 12 percent said they had used a GLP-1 agonist, with six percent saying they're currently using one. The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while the remaining 38 percent they took the medications just to lose weight.